Revance Therapeutics, Inc. earnings per share and revenue

RVNC earnings per share for the last quarter are -0.37 USD whereas the estimation was -0.27 USD which accounts for -37.54% surprise. Company revenue for the same period amounts to 59.88 M USD despite the estimated figure of 68.17 M USD. Estimated earnings per share for the next quarter are -0.19 USD, and revenue is expected to reach 84.09 M USD. Also watch annual changes over time to get a bigger picture of RVNC earnings per share and revenue dynamics.